Wei Huang

ResearcherID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 10

Top Venues

Journal of medicinal chemistry

Molecules (Basel, Switzerland)

ACS combinatorial science

Research (Washington, D.C.)

Central China Normal University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Central China Normal University

China

Associate Professor :: College of Chemistry

Publications

Ming-Shu Wang, Zhi-Zheng Wang, Zi-Long Li, Yi Gong, Cheng-Xiang Duan, Qian-Hui Cheng, Wei Huang, Guang-Fu Yang
Discovery of Macrocycle-Based HPK1 Inhibitors for T-Cell-Based Immunotherapy. Journal of medicinal chemistry 66 (1) (2022)
Ming-Shu Wang, Zhi-Zheng Wang, Zi-Long Li, Yi Gong, Cheng-Xiang Duan, Qian-Hui Cheng, Wei Huang, Guang-Fu Yang
Discovery of Macrocycle-Based HPK1 Inhibitors for T-Cell-Based Immunotherapy. Journal of medicinal chemistry 66 (1) (2022)
Ming-Shu Wang, Yi Gong, Lin-Sheng Zhuo, Xing-Xing Shi, Yan-Guang Tian, Chang-Kang Huang, Wei Huang, Guang-Fu Yang
Distribution- and Metabolism-Based Drug Discovery: A Potassium-Competitive Acid Blocker as a Proof of Concept. Research (Washington, D.C.) 2022 (2022)
Ming-Shu Wang, Zhi-Zheng Wang, Zi-Long Li, Yi Gong, Cheng-Xiang Duan, Qian-Hui Cheng, Wei Huang, Guang-Fu Yang
Discovery of Macrocycle-Based HPK1 Inhibitors for T-Cell-Based Immunotherapy. Journal of medicinal chemistry 66 (1) (2022)
Ming-Shu Wang, Zhi-Zheng Wang, Zi-Long Li, Yi Gong, Cheng-Xiang Duan, Qian-Hui Cheng, Wei Huang, Guang-Fu Yang
Discovery of Macrocycle-Based HPK1 Inhibitors for T-Cell-Based Immunotherapy. Journal of medicinal chemistry (2022)
Lin-Sheng Zhuo, Ming-Shu Wang, Feng-Xu Wu, Hong-Chuang Xu, Yi Gong, Zhi-Cheng Yu, Yan-Guang Tian, Chao Pang, Ge-Fei Hao, Wei Huang, Guang-Fu Yang
Discovery of Next-Generation Tropomyosin Receptor Kinase Inhibitors for Combating Multiple Resistance Associated with Protein Mutation. Journal of medicinal chemistry 64 (20) (2021)
Minhang Xin, Jiajia Sun, Wei Huang, Feng Tang, Zhaoyu Liu, Qiu Jin, Jia Wang
Design and synthesis of novel phthalazinone derivatives as potent poly(ADP-ribose)polymerase 1 inhibitors. Future medicinal chemistry 12 (19) (2020)
Ming-Shu Wang, Yi Gong, Zhi-Cheng Yu, Yan-Guang Tian, Lin-Sheng Zhuo, Wei Huang, Neng-Fang She
Grignard Reagent Utilization Enables a Practical and Scalable Construction of 3-Substituted 5-Chloro-1,6-naphthyridin-4-one Derivatives. Molecules (Basel, Switzerland) 25 (23) (2020)
Ming-Shu Wang, Hong-Chuang Xu, Yi Gong, Ren-Yu Qu, Lin-Sheng Zhuo, Wei Huang
Efficient Arylation of 2,7-Naphthyridin-1(2H)-one with Diaryliodonium Salts and Discovery of a New Selective MET/AXL Kinase Inhibitor. ACS combinatorial science 22 (9) (2020)
Haiyan Sun, Linsheng Zhuo, Huan Dong, Wei Huang, Nengfang She
Discovery of 8-Amino-Substituted 2-Phenyl-2,7-Naphthyridinone Derivatives as New c-Kit/VEGFR-2 Kinase Inhibitors. Molecules (Basel, Switzerland) 24 (24) (2019)

Wei Huang.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Wei Huang